Article
A genetic risk score to guide age-specific, personalized prostate cancer screening
2016-11-25
Abstract excerpt
<h4>Background</h4> Prostate-specific-antigen (PSA) screening resulted in reduced prostate cancer (PCa) mortality in a large clinical trial, but due to a high false-positive rate, among other concerns, many guidelines do not endorse universal screening and instead recommend an individualized decision based on each patient’s risk. Genetic risk may provide key information to guide the decisions of whether and at wh...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 05014be9-b194-5740-ae7c-b43e095b546b
- DOI
- 10.1101/089383
